CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Rekah Pharmaceutical Industry Ltd. Company Snapshot
Rekah Pharmaceutical Industry Ltd. (Rekah) is an Israel-based company which operates directly and through its subsidiaries. The Company operates two Good Manufacturing Practice (GMP) approved manufacturing sites, it has a marketing and distribution arm, a chain of pharmacies, and an export import unit. Rekah's plant covers approximately 5,000 square meters and was designed to take advantage of the most advanced and automated packaging techniques available. In April 1995, Rekah received the approval of the Ministry of Health for its new facility. The sterile department was designed to meet the standard of the United States Food and Drug Administration and was opened in February 1997. The Company distributes its products through Ophir & Shalpharm to institutional users such as Israel Health Funds, hospitals and government health facilities. Other subsidiaries include Vitamed Pharmaceutical Industry Ltd., CenterPharm, RITE, Talmor, BARBARA WOLF Ltd. and Madad.

Sales Analysis. Rekah Pharmaceutical Industry Ltd. reported sales of 218.39 million Israel Shekels (US$62.32 million) for the year ending December of 2016. This represents a decrease of 16.8% versus 2015, when the company's sales were 262.43 million Israel Shekels.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Rekah Pharmaceutical Industry Ltd.
  Stock Performance Chart for Rekah Pharmaceutical Industry Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/19/2017): 32.96
(Figures in Israel Shekels)
1 Week 2.3%   13 Weeks 1.1%  
4 Weeks 16.5%   52 Weeks 50.3%  
 
Rekah Pharmaceutical Industry Ltd. Key Data:
  Ticker: REKA Country: Israel
  Exchanges: TEL Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 218,385,000
(Year Ending Jan 2017).
Employees: 577
  Currency: Israel Shekels Market Cap: 319,339,717
  Fiscal Yr Ends: December Shares Outstanding: 9,688,705
  Share Type: Closely Held Shares: 4,024,491
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.